Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Guarini

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Forum (Genoa, Italy)|December 23, 1999
Biotechnologies in haematological malignanciesR Foà, G Reato, A Guarini
Reviews in Clinical and Experimental Hematology|August 7, 2001
Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemiaE Orsini, A Guarini, R Foa
British Journal of Cancer|December 1, 1992
IL2 treatment for cancer: from biology to gene therapyR Foa, A Guarini, B Gansbacher
British Journal of Haematology|May 12, 1998
Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blastsA Vitale, A Guarini, R Latagliata, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1980
Defibrination in adult acute lymphoblastic leukaemia. Report of four casesA Guarini, M Baccarani, G Corbelli, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Leukemia & Lymphoma|July 28, 2016
Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic LeukemiaR Foa, F Vischia, M Pini, et al.
Cytokines and Molecular Therapy|March 1, 1995
IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte responseA Guarini, B Gansbacher, K Cronin, et al.
Cancer Gene Therapy|April 19, 2000
Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor culturesA Cignetti, A Guarini, A Gillio Tos, et al.
Folia Biologica|January 1, 1994
Cytokine gene therapy in oncologyR Foa, A Cignetti, L Riera, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Forum (Genoa, Italy)|December 23, 1999
Biotechnologies in haematological malignanciesR Foà, G Reato, A Guarini
Reviews in Clinical and Experimental Hematology|August 7, 2001
Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemiaE Orsini, A Guarini, R Foa
British Journal of Cancer|December 1, 1992
IL2 treatment for cancer: from biology to gene therapyR Foa, A Guarini, B Gansbacher
British Journal of Haematology|May 12, 1998
Cytotoxic effectors activated by low-dose IL-2 plus IL-12 lyse IL-2-resistant autologous acute myeloid leukaemia blastsA Vitale, A Guarini, R Latagliata, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1980
Defibrination in adult acute lymphoblastic leukaemia. Report of four casesA Guarini, M Baccarani, G Corbelli, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Leukemia & Lymphoma|July 28, 2016
Use of the MTT Chemosensitivity Assay in B-Cell Chronic Lymphocytic LeukemiaR Foa, F Vischia, M Pini, et al.
Cytokines and Molecular Therapy|March 1, 1995
IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte responseA Guarini, B Gansbacher, K Cronin, et al.
Cancer Gene Therapy|April 19, 2000
Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor culturesA Cignetti, A Guarini, A Gillio Tos, et al.
Folia Biologica|January 1, 1994
Cytokine gene therapy in oncologyR Foa, A Cignetti, L Riera, et al.
Pageof 8